Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3?months

P. Meyrat; E. Safroneeva; A. M. Schoepfer

首页> 外文期刊>Alimentary Pharmacology & Therapeutics >Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3?months

【24h】

Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3?months

机译：利福昔明通过乳果糖氢呼气试验阳性对肠易激综合症的治疗可改善症状至少3个月

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

While rifaximin was able to improve symptoms in patients with irritable bowel syndrome (IBS) in phase III trials, these results are yet to be repeated in phase IV studies.

机译：尽管在III期临床试验中利福昔明能够改善肠易激综合征（IBS）患者的症状，但在IV期研究中仍需重复这些结果。

著录项

来源
《Alimentary Pharmacology & Therapeutics》 |2012年第12期|1084-1093|共10页
作者
P. Meyrat; E. Safroneeva; A. M. Schoepfer;
展开▼
作者单位

Private Practice for Gastroenterology and Hepatology Solothurn Switzerland;

Institute of Social and Preventive Medicine University of Bern Bern Switzerland;

Division of Gastroenterology and Hepatology Centre Hospitalier Universitaire Vaudois/CHUV Lausanne Switzerland;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3?months. [J] . P Meyrat, E Safroneeva, A M Schoepfer Alimentary pharmacology & therapeutics. . 2012,第11a12期

机译：利福昔明以乳果糖氢呼气试验阳性治疗肠易激综合症至少可改善症状3个月。
2. Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3?months. [J] . P Meyrat, E Safroneeva, A M Schoepfer Alimentary pharmacology & therapeutics. . 2012,第11a12期

机译：具有阳性乳糖氢气呼吸试验的肠易激综合征的Rifaximin治疗可改善症状至少3个月。
3. Use of Lactulose Breath Tests to Predict Response to Rifaximin in Irritable Bowel Syndrome With Diarrhea: The Positives and Negatives [J] . The American Journal of Gastroenterology . 2020,第6期

机译：利用乳糖呼吸试验预测腹泻肠易激综合征的鲁西昔明的反应：积极和底层
4. Different interventions for the treatment of irritable bowel syndrome-adjusted indirect comparison [C] . Qian Li, Wen-ting Liu, Jing-jun Xu, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：肠易激综合征调整后不同干预措施的间接比较
5. Mindfulness-Based Stress Reduction for the treatment of irritable bowel syndrome symptoms: A randomized waitlist control trial. [D] . Zernicke, Kristin. 2009

机译：基于正念的压力减轻治疗肠易激综合症的症状：一项随机的候补对照试验。
6. Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome [O] . Xiaojun Zhuang, Zhenyi Tian, Mei Luo, 2020

机译：腹泻型肠易激综合征的短程利福昔明治疗疗效和乳果糖氢呼气试验
7. Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months [O] . Meyrat P, Safroneeva E, Schoepfer A M 2012

机译：利福昔明乳果糖氢呼气试验阳性对肠易激综合征的治疗可改善症状至少3个月
8. Lactulose Breath Hydrogen Test for Small Bowel Bacterial Overgrowth and Small Bowel Transit Time [R] . Lemperle, B. 1983

机译：用于小肠细菌过度生长和小肠传输时间的乳果糖呼气氢测试

Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3?months

摘要

著录项

相似文献

相关主题

期刊订阅